Roivant Sciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ROIV and other ETFs, options, and stocks.

About ROIV

Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. 

CEO
Matthew Gline
CEOMatthew Gline
Employees
863
Employees863
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2014
Founded2014
Employees
863
Employees863

ROIV Key Statistics

Market cap
2.12B
Market cap2.12B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
896.40K
Average volume896.40K
High today
$3.09
High today$3.09
Low today
$2.87
Low today$2.87
Open price
$3.01
Open price$3.01
Volume
871.47K
Volume871.47K
52 Week high
$16.76
52 Week high$16.76
52 Week low
$2.52
52 Week low$2.52

Analyst ratings

100%

of 7 ratings
Buy
100%
Hold
0%
Sell
0%

ROIV Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.